OVID Competitors & Alternatives
Compare Ovid Therapeutics Inc with similar stocks in the same industry
Biotechnology
OVID
Main Stock$2.33
Tradestie Score
58
Market Cap
$97.42M
Revenue Growth
8.4%
Analyst Upside
+135.3%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
XOMA
XOMA Royalty Corporation Common Stock
|
$40.17
|
$474.20M | 28.2 | 56 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$7.73
|
$468.01M | - | 51 | Compare |
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$16.13
|
$463.20M | - | 60 | Compare |
|
SLDB
Solid Biosciences Inc. Common Stock
|
$8.04
|
$457.09M | - | 52 | Compare |
|
MRVI
Maravai LifeSciences Holdings, Inc. Class A Common Stock
|
$6.61
|
$454.29M | - | 55 | Compare |
|
RAPT
RAPT Therapeutics, Inc. Common Stock
|
$58.02
|
$450.49M | - | 53 | Compare |
|
MLTX
MoonLake Immunotherapeutics Class A Ordinary Shares
|
$17.85
|
$448.32M | - | 56 | Compare |
|
ATXS
Astria Therapeutics, Inc. Common Stock
|
$12.58
|
$425.52M | - | 58 | Compare |
|
ALMS
Alumis Inc. Common Stock
|
$27.27
|
$422.50M | - | 50 | Compare |
|
DRUG
Bright Minds Biosciences Inc. Common Stock
|
$74.96
|
$410.79M | - | 49 | Compare |
More OVID Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2834)
232 stocks in this industry